Genomadix logo

Genomadix

Lab Quality Results Without The Lab! Revolutionizing diagnostics with fast, portable, and accurate DNA results.

30 employees · est. 2021 · Kanata, Canada

VS
Leuko logo

Leuko

Non-invasive white blood cell monitoring

11 employees · est. 2017 · Boston, United States

Leuko is the older company (2021 vs 2017).

Side-by-Side Comparison

Genomadix Leuko
Founded
2021 2017 older
Headquarters
Kanata, Canada Boston, United States
Employees
30 11
Industry
Biotechnology Biotechnology, Health Care, Medical Devices
Funding Stage
Corporate Round Series A
Total Funding
Not tracked yet $100.00K
Funding Rounds
1 1
Services
Not tracked yet Non-invasive white cell monitoring, PointCheck1 device development
Target Customers
Not tracked yet Immunosuppressed patients, Chemotherapy patients, Home healthcare users, Local clinics
Taxonomy
DNA Diagnostics, Point Of Care Testing, Real-time QPCR, Molecular Diagnostics, Precision Medicine, Genotyping, Environmental Testing, Medical Devices, Personalized Medicine, Pharmacogenetics, Infectious Diseases, Water Safety Testing, Research And Development, Portable Diagnostics Non-invasive Medical Devices, White Blood Cell Monitoring, Medical Diagnostics, Biomedical Engineering, Immunosuppression Management, Clinical Outcomes, Chemotherapy Management, Infection Detection, Point-of-care Testing, MIT Research, Portable Medical Devices
Website
genomadix.com leuko.com
Genomadix logo

About Genomadix

Genomadix, headquartered in Ottawa, Canada, is advancing the field of Biotechnology with its innovative approach to diagnostics. Founded in 2021, the company is making waves with its real-time qPCR point of need technology that promises "Lab Quality Results Without The Lab!" The company is renowned...

Leuko logo

About Leuko

Leuko, founded in 2017, aims to revolutionize medical diagnostics with its non-invasive white blood cell monitoring technology. The company is pioneering the development of the first device capable of assessing white blood cells without the need for blood extraction. This innovation holds significan...

We will tell you when either one moves

BounceWatch watches Genomadix and Leuko for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Genomadix and Leuko — by email.

Frequently Asked Questions

Genomadix — Lab Quality Results Without The Lab! Revolutionizing diagnostics with fast, portable, and accurate DNA results.. Leuko — Non-invasive white blood cell monitoring. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Genomadix has raised undisclosed funding while Leuko has raised $100.00K.
Genomadix and Leuko operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Genomadix with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Genomadix on 13 Sep 2024, and Leuko on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy